Carroll Financial Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-94
Closed -$20K 1906
2021
Q1
$20K Hold
94
﹤0.01% 1035
2020
Q4
$10K Hold
94
﹤0.01% 1132
2020
Q3
$9K Hold
94
﹤0.01% 1080
2020
Q2
$11K Hold
94
﹤0.01% 1023
2020
Q1
$8K Buy
94
+5
+6% +$529 ﹤0.01% 1016
2019
Q4
$9K Hold
89
﹤0.01% 1114
2019
Q3
$10K Sell
89
-17
-16% -$2.58K ﹤0.01% 1020
2019
Q2
$18K Hold
106
﹤0.01% 864
2019
Q1
$17K Hold
106
﹤0.01% 799
2018
Q4
$12K Buy
106
+71
+203% +$9.31K ﹤0.01% 813
2018
Q3
$6K Hold
35
﹤0.01% 1054
2018
Q2
$4K Hold
35
﹤0.01% 1109
2018
Q1
$3K Hold
35
﹤0.01% 1131
2017
Q4
$4K Hold
35
﹤0.01% 1065
2017
Q3
$4K Buy
+35
New +$3.75K ﹤0.01% 1044

Other funds holding GWPH

Carroll Financial Associates's GWPH Position: Q2 2021 in Review

Carroll Financial Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 94 shares — an estimated $20K sold.

Carroll Financial Associates first reported a position in GWPH in Q3 2017 and held it in 15 quarters. The position peaked at $20K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Carroll Financial Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 94 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $20K.
  • Carroll Financial Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 15 quarters.
  • Carroll Financial Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $20K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.